Prognostic value of preprocedural neutrophil percentage-to-albumin ratio for in-hospital and overall mortality in patients with reduced ejection fraction undergoing transcatheter aortic valve implantation
- 1Department of Cardiology, University of Health Sciences Türkiye, Koşuyolu High Specialization Training and Research Hospital, Istanbul, Türkiye
Abstract
Introduction: Patients with reduced left ventricular ejection fraction (LVEF) undergoing transcatheter aortic valve implantation (TAVI) represent a particularly vulnerable subgroup with elevated perioperative and long-term mortality. The neutrophil percentage-to-albumin ratio (NPAR), an integrated marker of systemic inflammation and nutritional status, has not been specifically evaluated as a prognostic marker in this population.
Aim: To examine the prognostic value of preprocedural NPAR for in-hospital and overall (all-cause) mortality in patients with reduced LVEF undergoing TAVI.
Material and methods: This retrospective single-centre study enrolled 169 consecutive patients with severe aortic stenosis and LVEF < 50% undergoing TAVI between June 2020 and January 2026. Preprocedural NPAR was derived from blood samples obtained within 24 h before the procedure. In-hospital and overall mortality were assessed using logistic and Cox regression models with limited covariate adjustment.
Results: Using an NPAR cut-off of 20.74, patients with elevated NPAR exhibited higher rates of chronic kidney disease, acute kidney injury, and both in-hospital and overall mortality, along with higher C-reactive protein and BNP levels and lower haemoglobin, albumin, postprocedural LVEF, and tricuspid annular plane systolic excursion (TAPSE) values. NPAR remained associated with in-hospital mortality after adjustment for chronic kidney disease or TAPSE and was also associated with overall mortality in multivariable Cox regression analyses. Kaplan–Meier analysis demonstrated significantly reduced survival among patients with elevated NPAR.
Conclusions: After limited multivariable adjustment, preprocedural NPAR was associated with both in-hospital and overall mortality in patients with reduced LVEF undergoing TAVI. As a simple marker of inflammatory and nutritional burden, NPAR may provide additional prognostic information and complement preprocedural risk assessment, although its incremental value beyond established risk models and other biomarkers remains uncertain.
Related
- Development and external validation of a preprocedural prediction model for 1-year mortality after transcatheter aortic valve implantation
- Prognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy
- Prognostic value of pre- and post-procedural TAPSE/PASP ratio for long-term mortality in patients with left ventricular ejection fraction < 50% undergoing transcatheter aortic valve implantation
- Association between neutrophil percentage-to-albumin ratio and all-cause mortality in stroke survivors stratified by triglyceride-glucose index : A prospective observational study based on the NHANES database from 1999 to 2018
- Impact of preprocedural frailty on long-term mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis
BibTeX
@article{biyikli2026prognostic,
title = {{Prognostic value of preprocedural neutrophil percentage-to-albumin ratio for in-hospital and overall mortality in patients with reduced ejection fraction undergoing transcatheter aortic valve implantation}},
author = {Kadir Biyikli and Mustafa Ferhat Keten and Nesri Danısman and Dogancan Ceneli and Can Erdem},
journal = {Postepy w kardiologii interwencyjnej = Advances in interventional cardiology},
year = {2026},
month = sep,
doi = {10.5114/aic.2026.164689},
url = {https://europepmc.org/article/PMC/PMC13721062},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Prognostic value of preprocedural neutrophil percentage-to-albumin ratio for in-hospital and overall mortality in patients with reduced ejection fraction undergoing transcatheter aortic valve implantation
AU - Kadir Biyikli
AU - Mustafa Ferhat Keten
AU - Nesri Danısman
AU - Dogancan Ceneli
AU - Can Erdem
PY - 2026
DA - 2026/09/01
JO - Postepy w kardiologii interwencyjnej = Advances in interventional cardiology
DO - 10.5114/aic.2026.164689
UR - https://europepmc.org/article/PMC/PMC13721062
AB - Introduction: Patients with reduced left ventricular ejection fraction (LVEF) undergoing transcatheter aortic valve implantation (TAVI) represent a particularly vulnerable subgroup with elevated perioperative and long-term mortality. The neutrophil percentage-to-albumin ratio (NPAR), an integrated marker of systemic inflammation and nutritional status, has not been specifically evaluated as a prognostic marker in this population. Aim: To examine the prognostic value of preprocedural NPAR for in-hospital and overall (all-cause) mortality in patients with reduced LVEF undergoing TAVI. Material and methods: This retrospective single-centre study enrolled 169 consecutive patients with severe aortic stenosis and LVEF < 50% undergoing TAVI between June 2020 and January 2026. Preprocedural NPAR was derived from blood samples obtained within 24 h before the procedure. In-hospital and overall mortality were assessed using logistic and Cox regression models with limited covariate adjustment. Results: Using an NPAR cut-off of 20.74, patients with elevated NPAR exhibited higher rates of chronic kidney disease, acute kidney injury, and both in-hospital and overall mortality, along with higher C-reactive protein and BNP levels and lower haemoglobin, albumin, postprocedural LVEF, and tricuspid annular plane systolic excursion (TAPSE) values. NPAR remained associated with in-hospital mortality after adjustment for chronic kidney disease or TAPSE and was also associated with overall mortality in multivariable Cox regression analyses. Kaplan–Meier analysis demonstrated significantly reduced survival among patients with elevated NPAR. Conclusions: After limited multivariable adjustment, preprocedural NPAR was associated with both in-hospital and overall mortality in patients with reduced LVEF undergoing TAVI. As a simple marker of inflammatory and nutritional burden, NPAR may provide additional prognostic information and complement preprocedural risk assessment, although its incremental value beyond established risk models and other biomarkers remains uncertain.
SN - 1734-9338
SN - 1897-4295
ER -